LP-102 (LPOXY Therapeutics)

N/A

Report date: 2025/04/22 14:43:20
NME

Base Information

Drug NameLP-102 (LPOXY Therapeutics)
Drug Alias NameMetered-dose intestinal oxygen delivery therapeuticSidiprevLP-102
ClassificationOther
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsCrohn DiseaseColitis, UlcerativeColitis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesLPOXY Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesLPOXY Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsCrohn DiseaseColitis, UlcerativeColitis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A